Home > Insider Trading > Filing (0001209191-23-041478)

Filing Details

Accession Number:: 0001209191-23-041478
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-07-06 14:56:30
Reporting Period:: 2023-07-05

Accepted Time:: 2023-07-06 14:56:30
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
891024	Patterson Companies Inc.	PDCO	Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)	410886515

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1341608	Donald Zurbay	1031 Mendota Heights St. Paul MN 55120	President & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2023-07-05	1,666	$32.34	143,819	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,146	Indirect	By ESOP

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Employee Stock Options	$33.26		2033-07-01	93,633	93,633	Direct
Common Stock	Employee Stock Options	$28.99		2032-12-05	134,033	134,033	Direct
Common Stock	Employee Stock Options	$30.59		2032-07-01	35,895	35,895	Direct
Common Stock	Employee Stock Options	$30.77		2031-07-01	37,831	37,831	Direct
Common Stock	Employee Stock Options	$23.57		2030-07-14	57,819	57,819	Direct
Common Stock	Employee Stock Options	$22.25		2029-07-01	78,829	78,829	Direct
Common Stock	Employee Stock Options	$22.48	2021-07-01	2028-07-01	33,363	33,363	Direct
Common Stock	Employee Stock Options	$22.67		2028-06-29	99,250	99,250	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2033-07-01	93,633	93,633	Direct
2032-12-05	134,033	134,033	Direct
2032-07-01	35,895	35,895	Direct
2031-07-01	37,831	37,831	Direct
2030-07-14	57,819	57,819	Direct
2029-07-01	78,829	78,829	Direct
2028-07-01	33,363	33,363	Direct
2028-06-29	99,250	99,250	Direct

Footnotes

The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on April 5, 2023.
Includes an aggregate of 91,071 restricted stock units ("RSUs") awarded in the years 2020 through 2023 to Reporting Person pursuant to the Plan. The RSUs vest contingent upon continued employment as follows: 11,137 units vest 7/14/2023, 13,210 units vest 12/1/2023, 16,735 units vest 7/1/2024, 13,210 units vest 12/1/2024, 13,488 units vest 7/1/2025, 13,249 units vest on 12/1/2025 and 10,042 units vest 7/1/2026.
Represents shares of common stock indirectly held by the Reporting Person's Employee Stock Ownership Plan ("ESOP") account through May 1, 2023.
Stock options granted pursuant to the Plan on 7/1/2023.
Options are exercisable as follows: 33.3% on 7/1/2024, 33.3% on 7/1/2025 and 33.4% on 7/1/2026.
Stock options granted pursuant to the Plan on 12/5/2022.
Options are excercisable as follows: 33.3% on 12/5/2023, 33.3% on 12/5/2024 and 33.4% on 12/5/2025.
Stock options granted pursuant to the Plan on 7/1/2022.
Options are exercisable as follows: 33.3% on 7/1/2023, 33.3% on 7/1/2024 and 33.4% on 7/1/2025.
Stock options granted pursuant to the Plan on 7/1/2021.
Options are exercisable as follows: 33.3% on 7/1/2022, 33.3% on 7/1/2023 and 33.4% on 7/1/2024.
Stock options granted pursuant to the Plan on 7/14/2020.
Stock options granted pursuant to the Plan on 7/1/2019.
Options are exercisable as follows: 33.3% on 7/1/2020, 33.3% on 7/1/2021 and 33.4% on 7/1/2022.
Stock options granted pursuant to the Plan on 7/1/2018.
Stock options granted as an inducement award granted outside the Plan on 6/29/2018. The stock options granted would vest pro-rata over the course of 3 years, with one-third of the shares vesting on 6/29/2019, one-third vesting on 6/29/2020, and the remaining one-third vesting 6/29/2021, in all cases subject to continued employments.